Download PDF
Semin Neurol 2016; 36(06): 607-614
DOI: 10.1055/s-0036-1592356
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Movement Disorders in the Intensive Care Unit

Sara M. Schaefer
1   Department of Neurology, Yale University School of Medicine, New Haven, Connecticut
,
Rezvan Rostami
1   Department of Neurology, Yale University School of Medicine, New Haven, Connecticut
,
David M. Greer
1   Department of Neurology, Yale University School of Medicine, New Haven, Connecticut
› Author Affiliations
Further Information

Publication History

Publication Date:
01 December 2016 (online)

    Permissions and Reprints

Abstract

Movement disorders are common; yet to those without subspecialty experience they can be difficult to recognize, categorize, and manage. Although most frequently encountered in an outpatient setting, patients with movement disorders are commonly hospitalized and often admitted to the intensive care unit, leading to possible confusion about their proper care. In addition, movement disorders can arise in critical care settings for several reasons, including medication side effects, substance withdrawal, or development of a new syndrome. In this review, the authors explore the management of critically ill patients with movement disorders, new or established, including differential diagnosis, work-up, and treatment.

Keywords

movement disorder - intensive care - Parkinson's disease - NMDA encephalitis - dystonia - neuroleptic malignant syndrome - stiff person syndrome - tetanus - myoclonus
 

  • References

  • 1 Elias WJ, Shah BB. Tremor. JAMA 2014; 311 (9) 948-954
    CrossrefPubMedGoogle Scholar
  • 2 Robottom BJ, Factor SA, Weiner WJ. Movement disorders emergencies Part 2: hyperkinetic disorders. Arch Neurol 2011; 68 (6) 719-724
    PubMedGoogle Scholar
  • 3 Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol 1994; 35 (2) 239-243
    CrossrefPubMedGoogle Scholar
  • 4 Greer DM, Rosenthal ES, Wu O. Neuroprognostication of hypoxic-ischaemic coma in the therapeutic hypothermia era. Nat Rev Neurol 2014; 10 (4) 190-203
    CrossrefPubMedGoogle Scholar
  • 5 Greer DM. Unexpected good recovery in a comatose post-cardiac arrest patient with poor prognostic features. Resuscitation 2013; 84 (6) e81-e82
    CrossrefPubMedGoogle Scholar
  • 6 Celesia GG, Grigg MM, Ross E. Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies. Arch Neurol 1988; 45 (7) 781-784
    CrossrefPubMedGoogle Scholar
  • 7 Lucas JM, Cocchi MN, Salciccioli J , et al. Neurologic recovery after therapeutic hypothermia in patients with post-cardiac arrest myoclonus. Resuscitation 2012; 83 (2) 265-269
    CrossrefPubMedGoogle Scholar
  • 8 English WA, Giffin NJ, Nolan JP. Myoclonus after cardiac arrest: pitfalls in diagnosis and prognosis. Anaesthesia 2009; 64 (8) 908-911
    CrossrefPubMedGoogle Scholar
  • 9 Leite MA, Orsini M, de Freitas MR , et al. Another perspective on fasciculations: when is it not caused by the classic form of amyotrophic lateral sclerosis or progressive spinal atrophy?. Neurol Int 2014; 6 (3) 5208
    PubMedGoogle Scholar
  • 10 Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004; 107 (1) 1-16
    CrossrefPubMedGoogle Scholar
  • 11 Beckmann YY, Ciftçi Y, Seçil Y, Eren S. Fasciculations in brain death. Crit Care Med 2010; 38 (12) 2377-2378
    CrossrefPubMedGoogle Scholar
  • 12 Walker RH. Chorea. Continuum (Minneap Minn) 2013; 19 (5 Movement Disorders): 1242-1263
    PubMedGoogle Scholar
  • 13 Wild EJ, Tabrizi SJ. The differential diagnosis of chorea. Pract Neurol 2007; 7 (6) 360-373
    CrossrefPubMedGoogle Scholar
  • 14 Medlock MD, Cruse RS, Winek SJ , et al. A 10-year experience with postpump chorea. Ann Neurol 1993; 34 (6) 820-826
    CrossrefPubMedGoogle Scholar
  • 15 Surie S, Tijssen MA, Biervliet JD , et al. Chorea in adults following pulmonary endarterectomy. Move disord 2010; 25: 1101-1104
    CrossrefPubMedGoogle Scholar
  • 16 Jinnah HA, Factor SA. Diagnosis and treatment of dystonia. Neurol Clin 2015; 33 (1) 77-100
    CrossrefPubMedGoogle Scholar
  • 17 Manji H, Howard RS, Miller DH , et al. Status dystonicus: the syndrome and its management. Brain 1998; 121 (Pt 2): 243-252
    CrossrefPubMedGoogle Scholar
  • 18 Teive HA, Munhoz RP, Souza MM , et al. Status dystonicus: study of five cases. Arq Neuropsiquiatr 2005; 63 (1) 26-29
    CrossrefPubMedGoogle Scholar
  • 19 Mehta SH, Morgan JC, Sethi KD. Drug-induced movement disorders. Neurol Clin 2015; 33 (1) 153-174
    CrossrefPubMedGoogle Scholar
  • 20 Mallick IH, Winslet MC. A review of the epidemiology, pathogenesis and management of tetanus. Int J Surg 2004; 2 (2) 109-112
    CrossrefPubMedGoogle Scholar
  • 21 Maganti R, Gerber P, Drees C, Chung S. Nonconvulsive status epilepticus. Epilepsy Behav 2008; 12 (4) 572-586
    CrossrefPubMedGoogle Scholar
  • 22 Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 2007; 6 (4) 329-339
    CrossrefPubMedGoogle Scholar
  • 23 Hinson HE, Sheth KN. Manifestations of the hyperadrenergic state after acute brain injury. Curr Opin Crit Care 2012; 18 (2) 139-145
    CrossrefPubMedGoogle Scholar
  • 24 Diamond AL, Callison RC, Shokri J, Cruz-Flores S, Kinsella LJ. Paroxysmal sympathetic storm. Neurocrit Care 2005; 2 (3) 288-291
    CrossrefPubMedGoogle Scholar
  • 25 Munhoz RP, Scorr LM, Factor SA. Movement disorders emergencies. Curr Opin Neurol 2015; 28 (4) 406-412
    CrossrefPubMedGoogle Scholar
  • 26 Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142 (10) 1137-1145
    CrossrefPubMedGoogle Scholar
  • 27 Robottom BJ, Weiner WJ, Factor SA. Movement disorders emergencies. Part 1: hypokinetic disorders. Arch Neurol 2011; 68 (5) 567-572
    PubMedGoogle Scholar
  • 28 Heytens L, Forget P, Scholtès JL, Veyckemans F. The changing face of malignant hyperthermia: less fulminant, more insidious. Anaesth Intensive Care 2015; 43 (4) 506-511
    PubMedGoogle Scholar
  • 29 American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Association; 2013
    Google Scholar
  • 30 Wijemanne S, Jankovic J. Movement disorders in catatonia. J Neurol Neurosurg Psychiatry 2014; 87: 220-221
    PubMedGoogle Scholar
  • 31 Saddawi-Konefka D, Berg SM, Nejad SH, Bittner EA. Catatonia in the ICU: an important and underdiagnosed cause of altered mental status. a case series and review of the literature*. Crit Care Med 2014; 42 (3) e234-e241
    CrossrefPubMedGoogle Scholar
  • 32 Ahlskog JE. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls. Mayo Clin Proc 2014; 89 (7) 997-1003
    CrossrefPubMedGoogle Scholar
  • 33 Cooper MK, Brock DG, McDaniel CM. Interaction between levodopa and enteral nutrition. Ann Pharmacother 2008; 42 (3) 439-442
    CrossrefPubMedGoogle Scholar
  • 34 Bonnici A, Ruiner CE, St-Laurent L, Hornstein D. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay. Ann Pharmacother 2010; 44 (9) 1504-1507
    CrossrefPubMedGoogle Scholar
  • 35 Mizuno J, Kato S, Watada M, Morita S. [Perioperative management of a patient with Parkinson's disease with intravenous infusion of levodopa]. Masui 2009; 58 (10) 1286-1289
    PubMedGoogle Scholar
  • 36 Wright JJ, Goodnight PD, McEvoy MD. The utility of ketamine for the preoperative management of a patient with Parkinson's disease. Anesth Analg 2009; 108 (3) 980-982
    CrossrefPubMedGoogle Scholar
  • 37 Sharma JC, Macnamara L, Hasoon M, Vassallo M. Diagnostic and therapeutic value of apomorphine in Parkinsonian patients. Int J Clin Pract 2004; 58 (11) 1028-1032
    CrossrefPubMedGoogle Scholar
  • 38 Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 2001; 345 (26) 1870-1876
    CrossrefPubMedGoogle Scholar
  • 39 Sidransky MA, Tran NV, Kaye AD. Anesthesia considerations in stiff person syndrome. Middle East J Anaesthesiol 2013; 22 (2) 217-221
    PubMedGoogle Scholar
  • 40 Turner MR, Irani SR, Leite MI, Nithi K, Vincent A, Ansorge O. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology 2011; 77 (5) 439-443
    CrossrefPubMedGoogle Scholar
  • 41 Davies G, Irani SR, Coltart C , et al. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med 2010; 38 (2) 679-682
    CrossrefPubMedGoogle Scholar
  • 42 Howard CM, Kass JS, Bandi VD, Guntupalli KK. Challenges in providing critical care for patients with anti-N-methyl-D-aspartate receptor encephalitis. Chest 2014; 145 (5) 1143-1147
    CrossrefPubMedGoogle Scholar
  • 43 Malter MP, Elger CE, Surges R. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis. Seizure 2013; 22 (2) 136-140
    CrossrefPubMedGoogle Scholar
  • 44 Mann AP, Grebenciucova E, Lukas RV. Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges. Ther Clin Risk Manag 2014; 10: 517-525
    PubMedGoogle Scholar
  • 45 Mittal MK, Rabinstein AA, Hocker SE, Pittock SJ, , M Wijdicks E, McKeon A. Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care 2016; 24 (2) 240-250
    CrossrefPubMedGoogle Scholar
  • 46 Jankovic J, Fahn S. Physiologic and pathologic tremors. Diagnosis, mechanism, and management. Ann Intern Med 1980; 93 (3) 460-465
    CrossrefPubMedGoogle Scholar